TOUR [Tuniu] F-1/A: PROSPECTUS (Subject to Completion) Issued May 6, 2014

[PROSPECTUS (Subject to Completion) Issued May 6, 2014 8,000,000 American Depositary Shares Tuniu Corporation REPRESENTING 24,000,000 CLASS A ORDINARY SHARES US$ US$ US$ Tuniu Corporation is offering 7,380,000 American depositary shares, or ADSs, and the selling shareholders are offering 620,000 ADSs. Each ADS represents three Class A ordinary shares, par value US$ Upon completion of this offering, we will have] [[8,000,000] American Depository Shares Each Representing Three Class A Ordinary Shares, Par Value US$0.0001 Per Share TUNIU CORPORATION UNDERWRITING AGREEMENT Morgan Stanley & Co. International plc 25 Cabot Square, Canary Wharf London, E14 4QA United Kingdom Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, N.Y. 10010 China Renaissance Securities (Hong Kong) Limited Unit 901, Agricultural Bank of China] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the use in this Registration Statement on Form F-1 of Tuniu Corporation of our report dated March 6, 2014, except for the stock option grant, the adoption of the 2014 Share Incentive Plan, the private placement and the modifications to the Company’s Memorandum and Articles of Association and Series]

By | 2016-03-18T07:26:43+00:00 May 6th, 2014|Categories: Chinese Stocks, TOUR, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT April 30, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8551-6696 o o o]

By | 2016-03-19T15:42:17+00:00 May 6th, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM

[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT April 30, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8551-6696 o o o]

By | 2016-03-19T15:43:20+00:00 May 6th, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

MONT [MONTAGE TECHNOLOGY] 8-K: (Original Filing)

[Montage Technology Reports First Quarter 2014 Financial Results Memory Interface Revenue Increases 68.7% Sequentially; Gross Margin Improves to 63.9% SHANGHAI, China – May 6, 2014 First Quarter 2014 Highlights: • Attained revenue of $35.6 million, an increase of 77.2 percent year-over-year; • Increased memory interface product revenue by 68.7 percent over the fourth quarter; • Reported gross margin of 63.9] [Item 2.02 Results of Operations and Financial Condition Item 9.01 99.1 Press Release dated May 6, 2014]

By | 2016-03-20T01:43:38+00:00 May 6th, 2014|Categories: Chinese Stocks, MONT, SEC Original|Tags: , , , , , |0 Comments

MONT [MONTAGE TECHNOLOGY] 8-K: Montage Technology Reports First Quarter 2014 Financial Results

[Montage Technology Reports First Quarter 2014 Financial Results Memory Interface Revenue Increases 68.7% Sequentially; Gross Margin Improves to 63.9% SHANGHAI, China – May 6, 2014 First Quarter 2014 Highlights: • Attained revenue of $35.6 million, an increase of 77.2 percent year-over-year; • Increased memory interface product revenue by 68.7 percent over the fourth quarter; • Reported gross margin of 63.9] [Item 2.02 Results of Operations and Financial Condition Item 9.01 99.1 Press Release dated May 6, 2014]

By | 2016-03-20T01:44:34+00:00 May 6th, 2014|Categories: Chinese Stocks, MONT, Webplus ver|Tags: , , , , , |0 Comments

CHLN [China Housing & Land Development] 8-K: (Original Filing)

[Resignation Letter of Mr. Heung Sang Fong 发件人 : dexterfong0@gmail.com 日期 : 年 月 日 收件人 : nicolalu@gmail.com 抄送 : cangsang@gmail.com 主题 : My resignation Jing: Please accept this email as my formal resignation from the position of directorship of the company due to personal reasons. My resignation will be effective as of May 1, 2014. It has been my] []

CHLN [China Housing & Land Development] 8-K: Resignation Letter of Mr. Heung Sang Fong 发件人

[Resignation Letter of Mr. Heung Sang Fong 发件人 : dexterfong0@gmail.com 日期 : 年 月 日 收件人 : nicolalu@gmail.com 抄送 : cangsang@gmail.com 主题 : My resignation Jing: Please accept this email as my formal resignation from the position of directorship of the company due to personal reasons. My resignation will be effective as of May 1, 2014. It has been my] []

JMEI [Jumei International] F-6: (Original Filing)

[] [] [Writer’s Direct Dial Emmet, Marvin & Martin, LLP Counsellors at Law _____ 120 Broadway New York, New York 10271 _____ (212) 238-3000 (212) 653-1760 _____ Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.emmetmarvin.com 177 Madison Avenue Morristown, New Jersey 07960 (973) 538-5600 Fax: (973) 538-6448 May 6, 2014 The Bank of New York Mellon, as Depositary 101 Barclay Street New York,]

By | 2016-03-22T12:27:27+00:00 May 6th, 2014|Categories: Chinese Stocks, JMEI, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar